Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Acorda Therapeutics USD -3632000 7.84M 2023-06
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Alterity Therapeutics Limited AUD -7772080 2.99M 2023-06
Amgen USD 1.27B 819M 2023-12
Arrowhead Research USD -136545000 28.22M 2023-12
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Cara Therapeutics USD -28898000 3.44M 2023-09
Cipla INR 14.44B 1.89B 2023-09
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -10628000 414K 2023-09
CSL USD 934.7M 1.2B 2023-06
Cytokinetics USD -127418000 5.15M 2023-12
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Grifols EUR 250.59M 7.19M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Heron Therapeutics USD -24929000 17.47M 2023-09
Insmed USD -178272000 30.6M 2023-12
Ligand Pharmaceuticals USD -3458000 6.54M 2023-12
MannKind USD 7.86M 2.76M 2023-12
Merck EUR 983M 14M 2023-09
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Acorda Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.